As of September 30, 2025, the average one-year price target for Revolution Medicines is $77.26/share. The forecasts range from a low of $64.64 to a high of $103.95. The average price target represents ...
Hosted on MSN
Piper Sandler Initiates Coverage of Revolution Medicines (RVMD) with an Overweight Rating
Revolution Medicines, Inc. (NASDAQ:RVMD) is one of the most promising future stocks according to Wall Street analysts. On August 18, Piper Sandler initiated coverage of Revolution Medicines, Inc.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results